MRI perfusion in determining pseudoprogression in patients with glioblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MRI perfusion in determining pseudoprogression in patients with glioblastoma

Published:2013-01 Issue:1 Volume:37 Page:41-49
ISSN:0899-7071
Container-title:Clinical Imaging
language:en
Short-container-title:Clinical Imaging

Author:

Young Robert J.,Gupta Ajay,Shah Akash D.,Graber Jerome J.,Chan Timothy A.,Zhang Zhigang,Shi Weiji,Beal Kathryn,Omuro Antonio M.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging

Reference49 articles.

1. Response criteria for phase II studies of supratentorial malignant glioma;Macdonald;J Clin Oncol,1990

2. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas;Brandsma;Lancet Oncol,2008

3. Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma;Chamberlain;J Neurooncol,2007

4. MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients;Brandes;J Clin Oncol,2008

5. Pseudoprogression after radiotherapy with concurrent temozolomide for high-grade glioma: clinical observations and working recommendations;Chaskis;Surg Neurol,2009

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond conventional imaging: Advancements in MRI for glioma malignancy prediction and molecular profiling;Magnetic Resonance Imaging;2024-10

2. Evaluating the Efficacy of Perfusion MRI and Conventional MRI in Distinguishing Recurrent Cerebral Metastasis from Brain Radiation Necrosis;Brain Sciences;2024-03-27

3. Advances in Neuro-Oncological Imaging: An Update on Diagnostic Approach to Brain Tumors;Cancers;2024-01-30

4. Low rCBV values in glioblastoma tumor progression under chemoradiotherapy;Neuroradiology;2024-01-06

5. Multiparametric Analysis Combining DSC-MR Perfusion and [18F]FET-PET is Superior to a Single Parameter Approach for Differentiation of Progressive Glioma from Radiation Necrosis;Clinical Neuroradiology;2023-12-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3